149 related articles for article (PubMed ID: 16895176)
1. [Endothelin].
Maeda S; Miyauchi T; Goto K
Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
[No Abstract] [Full Text] [Related]
2. [PAH and many other indications. Old and new endothelin receptor antagonists.].
Schmitz J; Holzgrabe U
Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
[No Abstract] [Full Text] [Related]
3. Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
Mayes MD
Arthritis Rheum; 2003 May; 48(5):1190-9. PubMed ID: 12746891
[No Abstract] [Full Text] [Related]
4. [Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage].
Kanno K; Hirata Y
Nihon Rinsho; 2004 Mar; 62 Suppl 3():164-8. PubMed ID: 15171363
[No Abstract] [Full Text] [Related]
5. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
Hachulla E; Coghlan JG
Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
[TBL] [Abstract][Full Text] [Related]
6. [Bosentan for treatment of heart failure].
Yoshimoto T; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
[No Abstract] [Full Text] [Related]
7. [Pathophysiological significance of endothelin in pulmonary hypertension].
Yoshibayashi M
Nihon Rinsho; 2004 Sep; 62 Suppl 9():644-7. PubMed ID: 15506466
[No Abstract] [Full Text] [Related]
8. [Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.].
Pabst S; Hammerstingl C; Nickenig G; Skowasch D
Pharm Unserer Zeit; 2010 Nov; 39(6):448-52. PubMed ID: 20967933
[No Abstract] [Full Text] [Related]
9. Current status of bosentan for treatment of pulmonary hypertension.
Raja SG; Dreyfus GD
Ann Card Anaesth; 2008; 11(1):6-14. PubMed ID: 18182753
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF
Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376
[No Abstract] [Full Text] [Related]
11. [The pharmacology of endothelin and its antagonist bosentan].
Clozel M; Roux S
Ann Endocrinol (Paris); 2000 Feb; 61(1):75-9. PubMed ID: 10790596
[TBL] [Abstract][Full Text] [Related]
12. [Endothelin and essential hypertension].
Kataoka K; Kurihara Y; Kurihara H
Nihon Rinsho; 2004 Sep; 62 Suppl 9():640-3. PubMed ID: 15506465
[No Abstract] [Full Text] [Related]
13. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
Pittrow D; Kirch W
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
[No Abstract] [Full Text] [Related]
14. Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.
Foley RJ; Metersky ML
Respiration; 2008; 75(2):211-4. PubMed ID: 16293957
[TBL] [Abstract][Full Text] [Related]
15. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep.
Snapper JR; Thabes JS; Lefferts PL; Lu W
Am J Respir Crit Care Med; 1998 Jan; 157(1):81-8. PubMed ID: 9445282
[TBL] [Abstract][Full Text] [Related]
17. Bosentan for the treatment of adult pulmonary hypertension.
Dwyer N; Kilpatrick D
Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
[TBL] [Abstract][Full Text] [Related]
18. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
19. Bosentan.
Chin K; Channick R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
[TBL] [Abstract][Full Text] [Related]
20. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
